Effects of Maresin 1 (MaR1) on Colonic Inflammation and Gut Dysbiosis in Diet-Induced Obese Mice
Open Access
- 30 July 2020
- journal article
- research article
- Published by MDPI AG in Microorganisms
- Vol. 8 (8) , 1156
Abstract
The aim of this study was to characterize the effects of Maresin 1 (MaR1), a DHA-derived pro-resolving lipid mediator, on obesity-related colonic inflammation and gut dysbiosis in diet-induced obese (DIO) mice. In colonic mucosa of DIO mice, the MaR1 treatment decreased the expression of inflammatory genes, such as Tnf-α and Il-1β. As expected, the DIO mice exhibited significant changes in gut microbiota composition at the phylum, genus, and species levels, with a trend to a higher Firmicutes/Bacteroidetes ratio. Deferribacteres and Synergistetes also increased in the DIO animals. In contrast, these animals exhibited a significant decrease in the content of Cyanobacteria and Actinobacteria. Treatment with MaR1 was not able to reverse the dysbiosis caused by obesity on the most abundant phyla. However, the MaR1 treatment increased the content of P. xylanivorans, which have been considered to be a promising probiotic with healthy effects on gut inflammation. Finally, a positive association was found between the Deferribacteres and Il-1β expression, suggesting that the increase in Deferribacteres observed in obesity could contribute to the overexpression of inflammatory cytokines in the colonic mucosa. In conclusion, MaR1 administration ameliorates the inflammatory state in the colonic mucosa and partially compensates changes on gut microbiota caused by obesity.Keywords
Funding Information
- Department of Health of the Navarra Government (67-2015)
- MINECO/FEDER (BFU2012-36089, BFU2015-65937-R)
- CIBER Physiopathology of Obesity and Nutrition (CIBERobn) (CB12/03/30002)
This publication has 78 references indexed in Scilit:
- Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls painThe FASEB Journal, 2012
- Role of intestinal inflammation as an early event in obesity and insulin resistanceCurrent Opinion in Clinical Nutrition and Metabolic Care, 2011
- High-Fat Diet: Bacteria Interactions Promote Intestinal Inflammation Which Precedes and Correlates with Obesity and Insulin Resistance in MousePLOS ONE, 2010
- High-Fat Diet Determines the Composition of the Murine Gut Microbiome Independently of ObesityGastroenterology, 2009
- Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actionsJournal of Experimental Medicine, 2008
- A core gut microbiome in obese and lean twinsNature, 2008
- Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediatorsNature Reviews Immunology, 2008
- Human gut microbes associated with obesityNature, 2006
- An obesity-associated gut microbiome with increased capacity for energy harvestNature, 2006
- Statistical significance for genomewide studiesProceedings of the National Academy of Sciences of the United States of America, 2003